ZYME Q4 2023 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M-95.8% YoY

Gross Profit

$17M100.0% margin

Operating Income

-$23M-138.4% margin

Net Income

-$14M-85.6% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+2.5%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$12M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$581M

Total Liabilities

$116M

Stockholders' Equity

$465M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$402M	-95.8%
Gross Profit	$17M	$350M	-95.2%
Operating Income	-$23M	$319M	-107.3%
Net Income	-$14M	$309M	-104.7%

Revenue Segments

Upfront Fee

$18M100%